Definitive Healthcare (NASDAQ:DH) Stock Rating Lowered by Zacks Research

Definitive Healthcare (NASDAQ:DH) was downgraded by stock analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Thursday,Zacks.com reports.

A number of other equities analysts have also recently issued reports on DH. Canaccord Genuity Group cut their target price on shares of Definitive Healthcare from $4.00 to $3.00 and set a “hold” rating for the company in a research report on Friday, February 27th. Morgan Stanley restated an “underperform” rating and set a $3.50 price objective on shares of Definitive Healthcare in a research report on Thursday, December 18th. Wall Street Zen lowered Definitive Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, February 28th. William Blair raised Definitive Healthcare to a “strong-buy” rating in a research report on Thursday, November 6th. Finally, Stephens cut their price target on Definitive Healthcare from $3.00 to $2.00 and set an “equal weight” rating for the company in a report on Friday, February 27th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have given a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus price target of $3.52.

Definitive Healthcare Price Performance

Definitive Healthcare stock traded down $0.04 during trading hours on Thursday, hitting $1.18. The stock had a trading volume of 252,425 shares, compared to its average volume of 368,888. Definitive Healthcare has a 1-year low of $1.07 and a 1-year high of $4.70. The stock has a market capitalization of $166.80 million, a price-to-earnings ratio of -0.94 and a beta of 1.66. The stock’s fifty day moving average is $2.04 and its two-hundred day moving average is $2.79. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.64 and a quick ratio of 1.64.

Institutional Investors Weigh In On Definitive Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. AQR Capital Management LLC boosted its stake in Definitive Healthcare by 56.7% in the 1st quarter. AQR Capital Management LLC now owns 590,149 shares of the company’s stock worth $1,706,000 after buying an additional 213,562 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Definitive Healthcare by 564.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company’s stock worth $25,191,000 after acquiring an additional 7,404,363 shares during the period. Jane Street Group LLC boosted its position in shares of Definitive Healthcare by 166.0% in the first quarter. Jane Street Group LLC now owns 105,114 shares of the company’s stock worth $304,000 after acquiring an additional 65,597 shares during the last quarter. Bank of Montreal Can purchased a new stake in Definitive Healthcare in the second quarter valued at approximately $71,000. Finally, Savant Capital LLC purchased a new stake in Definitive Healthcare in the second quarter valued at approximately $45,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.